Human gastric mucin: identification of a unique species by expression cloning
Toribara, N.W, Roberton, A.M, Ho, S.B, Kuo, W.L, Gum, E, Hicks, J.W, Gum, J.R. Jr, Byrd, J.C, Siddiki, B, Kim, Y.S
Published in The Journal of biological chemistry (15.03.1993)
Published in The Journal of biological chemistry (15.03.1993)
Get full text
Journal Article
Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL
Woyach, Jennifer A, Ruppert, Amy S, Heerema, Nyla A, Zhao, Weiqiang, Booth, Allison M, Ding, Wei, Bartlett, Nancy L, Brander, Danielle M, Barr, Paul M, Rogers, Kerry A, Parikh, Sameer A, Coutre, Steven, Hurria, Arti, Brown, Jennifer R, Lozanski, Gerard, Blachly, James S, Ozer, Hatice G, Major-Elechi, Brittny, Fruth, Briant, Nattam, Sreenivasa, Larson, Richard A, Erba, Harry, Litzow, Mark, Owen, Carolyn, Kuzma, Charles, Abramson, Jeremy S, Little, Richard F, Smith, Scott E, Stone, Richard M, Mandrekar, Sumithra J, Byrd, John C
Published in The New England journal of medicine (27.12.2018)
Published in The New England journal of medicine (27.12.2018)
Get full text
Journal Article
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
Byrd, John C, Brown, Jennifer R, O'Brien, Susan, Barrientos, Jacqueline C, Kay, Neil E, Reddy, Nishitha M, Coutre, Steven, Tam, Constantine S, Mulligan, Stephen P, Jaeger, Ulrich, Devereux, Steve, Barr, Paul M, Furman, Richard R, Kipps, Thomas J, Cymbalista, Florence, Pocock, Christopher, Thornton, Patrick, Caligaris-Cappio, Federico, Robak, Tadeusz, Delgado, Julio, Schuster, Stephen J, Montillo, Marco, Schuh, Anna, de Vos, Sven, Gill, Devinder, Bloor, Adrian, Dearden, Claire, Moreno, Carol, Jones, Jeffrey J, Chu, Alvina D, Fardis, Maria, McGreivy, Jesse, Clow, Fong, James, Danelle F, Hillmen, Peter
Published in The New England journal of medicine (17.07.2014)
Published in The New England journal of medicine (17.07.2014)
Get full text
Journal Article
Corrections to “Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness”
Czuczman, M.S., Leonard, J.P., Jung, S., Johnson, J.L., Hsi, E.D., Byrd, J.C., Cheson, B.D.
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia
Eisfeld, A-K, Mrózek, K, Kohlschmidt, J, Nicolet, D, Orwick, S, Walker, C J, Kroll, K W, Blachly, J S, Carroll, A J, Kolitz, J E, Powell, B L, Wang, E S, Stone, R M, de la Chapelle, A, Byrd, J C, Bloomfield, C D
Published in Leukemia (01.10.2017)
Published in Leukemia (01.10.2017)
Get full text
Journal Article
Dinaciclib is a novel cyclin-dependent kinase inhibitor with significant clinical activity in relapsed and refractory chronic lymphocytic leukemia
Flynn, J, Jones, J, Johnson, A J, Andritsos, L, Maddocks, K, Jaglowski, S, Hessler, J, Grever, M R, Im, E, Zhou, H, Zhu, Y, Zhang, D, Small, K, Bannerji, R, Byrd, J C
Published in Leukemia (01.07.2015)
Published in Leukemia (01.07.2015)
Get full text
Journal Article
Incidence and description of autoimmune cytopenias during treatment with ibrutinib for chronic lymphocytic leukemia
Rogers, K A, Ruppert, A S, Bingman, A, Andritsos, L A, Awan, F T, Blum, K A, Flynn, J M, Jaglowski, S M, Lozanski, G, Maddocks, K J, Byrd, J C, Woyach, J A, Jones, J A
Published in Leukemia (01.02.2016)
Published in Leukemia (01.02.2016)
Get full text
Journal Article
CN4 Patient-Reported Outcomes from the Phase 3, Randomized Study of Acalabrutinib with or without Obinutuzumab Versus Chlorambucil PLUS Obinutuzumab for Treatment-Naïve Chronic Lymphocytic Leukemia (ELEVATE-TN)
Walker, P., Sharman, J.P., Jurczak, W., Munir, T., Banerji, V., Coutre, S., Woyach, J., Salles, G., Wierda, W.G., Patel, P., Wang, M.H., Emeribe, U., Flood, E., Byrd, J.C., Ghia, P.
Published in Value in health (01.06.2021)
Published in Value in health (01.06.2021)
Get full text
Journal Article
Application of a sequential multiple assignment randomized trial (SMART) design in older patients with chronic lymphocytic leukemia
Ruppert, A.S., Yin, J., Davidian, M., Tsiatis, A.A., Byrd, J.C., Woyach, J.A., Mandrekar, S.J.
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article
Autologous hematopoietic stem cell transplant induces the molecular aging of T-cells in multiple myeloma
Rosko, A, Hofmeister, C, Benson, D, Efebera, Y, Huang, Y, Gillahan, J, Byrd, J C, Burd, C E
Published in Bone marrow transplantation (Basingstoke) (01.10.2015)
Published in Bone marrow transplantation (Basingstoke) (01.10.2015)
Get full text
Journal Article
The novel cyclin-dependent kinase inhibitor dinaciclib (SCH727965) promotes apoptosis and abrogates microenvironmental cytokine protection in chronic lymphocytic leukemia cells
Johnson, A J, Yeh, Y-Y, Smith, L L, Wagner, A J, Hessler, J, Gupta, S, Flynn, J, Jones, J, Zhang, X, Bannerji, R, Grever, M R, Byrd, J C
Published in Leukemia (01.12.2012)
Published in Leukemia (01.12.2012)
Get full text
Journal Article
Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness
Czuczman, M.S., Leonard, J.P., Jung, S., Johnson, J.L., Hsi, E.D., Byrd, J.C., Cheson, B.D.
Published in Annals of oncology (01.09.2012)
Published in Annals of oncology (01.09.2012)
Get full text
Journal Article
Complex Karyotype Predicts Poor Response To Salvage Therapy And Ineligibility For Reduced Intensity Conditioning Transplantation In CLL
Jaglowski, S.M, Heerema, N, Elder, P, Scholl, D, Hamadani, M, Byrd, J.C, Devine, S, Andritsos, L.A
Published in Biology of blood and marrow transplantation (2010)
Published in Biology of blood and marrow transplantation (2010)
Get full text
Journal Article
Phase I Study Of Vorinostat (SAHA) After Autologous Transplant For Patients With High Risk Lymphoma
Hofmeister, C.C, Lozanski, G, Baiocchi, R.A, Hade, E.M, Benson, D.M, Blum, K, Porcu, P, Byrd, J.C, Devine, S.M
Published in Biology of blood and marrow transplantation (2010)
Published in Biology of blood and marrow transplantation (2010)
Get full text
Journal Article
Tumor antigen ROR1 targeted drug delivery mediated selective leukemic but not normal B-cell cytotoxicity in chronic lymphocytic leukemia
Mani, R, Mao, Y, Frissora, F W, Chiang, C-L, Wang, J, Zhao, Y, Wu, Y, Yu, B, Yan, R, Mo, X, Yu, L, Flynn, J, Jones, J, Andritsos, L, Baskar, S, Rader, C, Phelps, M A, Chen, C-S, Lee, R J, Byrd, J C, Lee, L J, Muthusamy, N
Published in Leukemia (01.02.2015)
Published in Leukemia (01.02.2015)
Get full text
Journal Article
Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: a novel epigenetic-targeting approach in acute myeloid leukemia
Mims, A, Walker, A R, Huang, X, Sun, J, Wang, H, Santhanam, R, Dorrance, A M, Walker, C, Hoellerbauer, P, Tarighat, S S, Chan, K K, Klisovic, R B, Perrotti, D, Caligiuri, M A, Byrd, J C, Chen, C-S, James Lee, L, Jacob, S, Mrózek, K, Bloomfield, C D, Blum, W, Garzon, R, Schwind, S, Marcucci, G
Published in Leukemia (01.04.2013)
Published in Leukemia (01.04.2013)
Get full text
Journal Article
Outcome of patients with relapsed or refractory chronic lymphocytic leukemia treated with flavopiridol: impact of genetic features
Woyach, J A, Lozanski, G, Ruppert, A S, Lozanski, A, Blum, K A, Jones, J A, Flynn, J M, Johnson, A J, Grever, M R, Heerema, N A, Byrd, J C
Published in Leukemia (01.06.2012)
Published in Leukemia (01.06.2012)
Get full text
Journal Article
Mitochondrial priming of chronic lymphocytic leukemia patients associates Bcl-[x.sub.L] dependence with alvocidib response
Pierceall, W.E, Warner, S.L, Lena, R.J, Doykan, C, Blake, N, Elashoff, M, Hoff, D.V, Bearss, D.J, Cardone, M.H, Andritsos, L, Byrd, J.C, Lanasa, M.C, Grever, M.R, Johnson, A.J
Published in Leukemia (01.11.2014)
Get full text
Published in Leukemia (01.11.2014)
Journal Article
miR-155 expression is associated with chemoimmunotherapy outcome and is modulated by Bruton’s tyrosine kinase inhibition with Ibrutinib
Guinn, D, Ruppert, A S, Maddocks, K, Jaglowski, S, Gordon, A, Lin, T S, Larson, R, Marcucci, G, Hertlein, E, Woyach, J, Johnson, A J, Byrd, J C
Published in Leukemia (01.05.2015)
Published in Leukemia (01.05.2015)
Get full text
Journal Article